Efficacy And Safety Propel The Convalescent Plasma Therapy Market: Major Factor in the Transformation of the Convalescent Plasma Therapy Market in 2025

How Will the Convalescent Plasma Therapy Market Grow, and What Is the Projected Market Size?
In recent times, the market size for convalescent plasma therapy has seen a swift expansion. Its growth is projected to increase from $0.05 billion in 2024 to $0.06 billion in 2025, maintaining a compound annual growth rate (CAGR) of 11.4%. This surge in the historic period can be credited to conditions like pandemics and infectious disease occurrences, advancements in immunotherapy research, emergency use authorization (eua), the availability of patients, and awareness among clinicians and the public.

Anticipated to grow quickly in the forthcoming years, the convalescent plasma therapy market's value is predicted to reach $0.09 billion by 2029, representing a compound annual growth rate (CAGR) of 13.7%. The forecasted growth can be linked to factors such as the evolution of pathogens, the advancement of immunotherapies, changes in regulatory frameworks, worldwide preparedness, and public health initiatives. Key trends projected during this period comprise of standardized collection and processing, specific plasma components, customized treatment, telemedicine and remote patient monitoring, as well as research into long-term effects.

What Key Elements Are Boosting Growth in the Convalescent Plasma Therapy Market?
The growth of the market for CPT in COVID-19 patients could be largely influenced by the higher effectiveness and safety observed during trials held during the projected period. The convalescent plasma transfusion has historically been utilized in managing various infectious disease outbreaks such as SARS-1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. A study carried out by the Houston Methodist hospital in June 2022 that intended to assess the safety and effectiveness of COVID-19 convalescent plasma therapy revealed that the therapy is not only safe with zero reported adverse events but also has a recovery rate of 76%. A study released in the Journal of Medical Virology in May 2020 suggested that convalescent plasma therapy could lead to a reduced mortality rate in seriously ill patients, observable beneficial effects on clinical symptoms, an increase in neutralizing antibody titers, and disappearance of SARS-CoV-2 RNA. The safety and effectiveness of convalescent plasma therapy in COVID-19 patients is expected to propel the growth of the global convalescent plasma therapy market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

Who Are the Major Industry Players Fueling Convalescent Plasma Therapy Market Expansion?
Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

Which Key Developments Are Influencing the Convalescent Plasma Therapy Market?
The progression of immunotherapy based on antibodies as a potential treatment for COVID-19 highlights growth prospects for the convalescent plasma therapy market. Convalescent plasma therapy uses antibodies created in response to the coronavirus in the donor, to enhance the recipient's immune response. Various companies are beginning trials, engaging in partnerships and investing in antibody-based therapy for COVID-19. In August 2023, Regeneron Pharmaceuticals Inc., an American biotech firm, collaborated with the Biomedical Advanced Research and Development Authority (BARDA) to facilitate the clinical progress, clinical production, and regulatory approval procedures for emerging COVID-19 monoclonal antibody therapies to prevent SARS-CoV-2 infection. This collaboration is under the auspices of Project NextGen, a U.S. Department of Health and Human Services (HHS) initiative to generate a flow of innovative COVID-19 vaccines and treatments. In line with the project's framework, Regeneron will independently formulate and propose an antibody candidate, which will be evaluated and chosen by both BARDA and Regeneron for further research, production, and regulatory activities. With the use of antibodies in convalescent plasma therapy, the attention on antibody-based COVID-19 therapy is anticipated to spur market growth.

How Is the Segmentation of the Convalescent Plasma Therapy Market Defined?
The convalescent plasma therapy market covered in this report is segmented -

1) By Antibody type: IgM, IgG, IgA
2) By Application: Prophylaxis, Treatment
3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:
1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products
2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products
3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

What Is the Leading Region in the Convalescent Plasma Therapy Market?
North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Convalescent Plasma Therapy Global Market Report?

- Market Size Analysis: Analyze the Convalescent Plasma Therapy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Convalescent Plasma Therapy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Convalescent Plasma Therapy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Convalescent Plasma Therapy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3233

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.